16-57245373-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012106.4(ARL2BP):c.6C>A(p.Asp2Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,607,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012106.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL2BP | NM_012106.4 | c.6C>A | p.Asp2Glu | missense_variant | 1/6 | ENST00000219204.8 | NP_036238.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL2BP | ENST00000219204.8 | c.6C>A | p.Asp2Glu | missense_variant | 1/6 | 1 | NM_012106.4 | ENSP00000219204 | P1 | |
ARL2BP | ENST00000562023.5 | c.6C>A | p.Asp2Glu | missense_variant | 1/5 | 3 | ENSP00000457465 | |||
ARL2BP | ENST00000565794.1 | n.115C>A | non_coding_transcript_exon_variant | 1/2 | 5 | |||||
ARL2BP | ENST00000563234.1 | upstream_gene_variant | 2 | ENSP00000454237 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000129 AC: 3AN: 232700Hom.: 0 AF XY: 0.00000793 AC XY: 1AN XY: 126032
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1454788Hom.: 0 Cov.: 31 AF XY: 0.0000152 AC XY: 11AN XY: 722826
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74502
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1479063). This variant has not been reported in the literature in individuals affected with ARL2BP-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 2 of the ARL2BP protein (p.Asp2Glu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at